Could the HPV vaccine be used as a stopgap measure to avoid a ‘shithole countries’ health crisis?

The Obama Administration is reportedly pressing President Trump to approve an increase in the production of the transgendered health intervention, antiviral drug, cisvaginal cervical cancer vaccine, called Cologuard, in order to avoid having insufficient…

Could the HPV vaccine be used as a stopgap measure to avoid a ‘shithole countries’ health crisis?

The Obama Administration is reportedly pressing President Trump to approve an increase in the production of the transgendered health intervention, antiviral drug, cisvaginal cervical cancer vaccine, called Cologuard, in order to avoid having insufficient supplies in 2018 and ’19.

The National Institutes of Health announced a four-year, $115 million investment to ramp up production of the vaccine at a September 5 press conference.

According to CNN, the officials told reporters during a press conference last week that the government would do this by increasing the amount of human resources in the vaccine manufacturing industry, or performing a more aggressive approach to overseas procurement. However, the NIH officials made no comment on whether the move was a response to President Trump’s “shithole countries” tweet, which referenced a failed congressional hearing in response to Trump’s recent Cabinet appointees regarding their public comments about Mexican immigrants and others in general.

The Cologuard vaccine, also known as the Gardasil vaccine, was approved by the FDA for sexually active women between the ages of 19 and 49 in 2014 and is designed to protect against cervical cancer. According to CNN, the NIH officials acknowledged that there would likely be a shortage of the vaccine during the 2018 and 2019 immunization season.

“Getting vaccines to women in general, or cervical cancer patients in particular, by the time they are in middle age, is a real challenge that needs to be addressed,” Acting Director of the National Institute of Allergy and Infectious Diseases and leader of the HPV vaccine program Dr. Thomas Frieden said.

The AP reports that the new plan, dubbed the “Make Cologuard History Campaign,” will focus on encouraging women at “high risk” of cervical cancer to get the vaccine as soon as possible, which will likely address the President’s comments last week about not wanting to spend tax dollars on vaccines for women with certain countries. CNN reports:

“I just don’t want to spend hundreds of millions of dollars on vaccines that I don’t think are useful for our people,” Trump said during the White House’s daily press briefing Thursday. “I want our people to be safe. But many, many millions of dollars have been spent on vaccines.”

The vaccine has also been marketed as a preventative treatment for certain forms of precancerous cervical cells and genital warts. Advocates say it has proven to be a highly effective method of preventing the spread of genital warts, which are potentially life-threatening, and is recommended for women under the age of 21.

Read the full story at CNN.

Related

D.C. attorney raising awareness for cervical cancer among Muslim women

Sign language for ‘people of color’ get widespread attention

After Trump gets hit in the eye with a glass, his every breath might be recorded

Leave a Comment